Skip to main content
Clinical Trials/CTRI/2023/03/050394
CTRI/2023/03/050394
Recruiting
Phase 4

A prospective, open-label clinical study to evaluate performance and safety of the Phacoemulsification Machine with Accessories.

Grewal Eye Institute0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: H259- Unspecified age-related cataract
Sponsor
Grewal Eye Institute
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Grewal Eye Institute

Eligibility Criteria

Inclusion Criteria

  • 1\.Cataracts for which cataract extraction
  • and posterior chamber IOL implantation
  • have been planned \& possible
  • 2\.Availability, willingness, ability and
  • sufficient cognitive awareness to comply
  • with study requirements, examination
  • procedures and visits
  • 4\.Be willing to provide informed consent and
  • authorization to disclose protected health
  • information or equivalent documentation

Exclusion Criteria

  • 1\. Preoperative ocular pathology that can affect visual acuity
  • 2\. Corneal irregularities such as keratoconus, corneal dystrophy,
  • corneal opacities
  • 3\. Previous intraocular or corneal surgery
  • 4\. Other ocular surgery at the time of the cataract extraction
  • 5\. Subject with acute and chronic disease or illness that would
  • increase the operative risk or confound the outcomes of the
  • 6\. Subject with primary open angle or narrow angle glaucoma
  • 7\. Patient with cardiac pacemaker
  • 8\. Previous or pre\-existing ocular disease that would preclude post operative visual acuity of 20/60 or better subject with

Outcomes

Primary Outcomes

Not specified

Similar Trials